These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

126 related articles for article (PubMed ID: 9330964)

  • 1. Frequency of stages of Alzheimer-related lesions in different age categories: concurrences and cautions.
    Ball MJ
    Neurobiol Aging; 1997; 18(4):375-6; discussion 389-92. PubMed ID: 9330964
    [No Abstract]   [Full Text] [Related]  

  • 2. Frequency of stages of Alzheimer-related lesions in different age categories.
    Silverman W; Wisniewski HM; Bobinski M; Wegiel J
    Neurobiol Aging; 1997; 18(4):377-9; discussion 389-92. PubMed ID: 9330965
    [No Abstract]   [Full Text] [Related]  

  • 3. Neuropathological staging of Alzheimer-related lesions: the challenge of establishing relations to age.
    Jellinger KA
    Neurobiol Aging; 1997; 18(4):369-75; discussion 389-92. PubMed ID: 9330963
    [No Abstract]   [Full Text] [Related]  

  • 4. The natural history of Alzheimer neurofibrillary tangles and amyloid deposits.
    Hyman BT; Gomez-Isla T
    Neurobiol Aging; 1997; 18(4):386-7; discussion 389-92. PubMed ID: 9330968
    [No Abstract]   [Full Text] [Related]  

  • 5. The biological significance of neuropathological lesions in Alzheimer's disease.
    Mori H
    Neurobiol Aging; 1997; 18(4):379-82; discussion 389-92. PubMed ID: 9330966
    [No Abstract]   [Full Text] [Related]  

  • 6. Plaques and tangles: searching for primary events in a forest of data.
    Cummings BJ
    Neurobiol Aging; 1997; 18(4):358-62; discussion 389-92. PubMed ID: 9330962
    [No Abstract]   [Full Text] [Related]  

  • 7. Part III. Neuropathology of Alzheimer's disease.
    Arnold SE
    Dis Mon; 2000 Oct; 46(10):687-705. PubMed ID: 11078010
    [No Abstract]   [Full Text] [Related]  

  • 8. Frequency of stages of Alzheimer-related lesions in different age categories.
    Braak H; Braak E
    Neurobiol Aging; 1997; 18(4):351-7. PubMed ID: 9330961
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Diagnostic criteria for neuropathologic assessment of Alzheimer's disease.
    Braak H; Braak E
    Neurobiol Aging; 1997; 18(4 Suppl):S85-8. PubMed ID: 9330992
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Diagnosis and staging of Alzheimer disease.
    Duyckaerts C; Hauw JJ
    Neurobiol Aging; 1997; 18(4 Suppl):S33-42. PubMed ID: 9330983
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Position paper on diagnostic criteria for Alzheimer disease.
    Hansen LA; Terry RD
    Neurobiol Aging; 1997; 18(4 Suppl):S71-3. PubMed ID: 9330989
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The challenge of characterizing normal brain aging in relation to Alzheimer's disease.
    Morris JC
    Neurobiol Aging; 1997; 18(4):388-9; discussion 389-92. PubMed ID: 9330969
    [No Abstract]   [Full Text] [Related]  

  • 13. No difference in the prevalence of Alzheimer-type neurodegenerative changes in the brains of suicides when compared with controls: an explorative neuropathologic study.
    Matschke J; Sehner S; Gallinat J; Siegers J; Murroni M; Püschel K; Glatzel M
    Eur Arch Psychiatry Clin Neurosci; 2018 Aug; 268(5):509-517. PubMed ID: 29383449
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Neuropathological diagnosis of Alzheimer's disease: a perspective from longitudinal clinicopathological studies.
    Dickson DW
    Neurobiol Aging; 1997; 18(4 Suppl):S21-6. PubMed ID: 9330981
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinicopathologic correlations in a large Alzheimer disease center autopsy cohort: neuritic plaques and neurofibrillary tangles "do count" when staging disease severity.
    Nelson PT; Jicha GA; Schmitt FA; Liu H; Davis DG; Mendiondo MS; Abner EL; Markesbery WR
    J Neuropathol Exp Neurol; 2007 Dec; 66(12):1136-46. PubMed ID: 18090922
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Prevalence, incidence and duration of Braak's stages in the general population: can we know?
    Duyckaerts C; Hauw JJ
    Neurobiol Aging; 1997; 18(4):362-9; discussion 389-92. PubMed ID: 9380250
    [No Abstract]   [Full Text] [Related]  

  • 17. Active caspase-6 and caspase-6-cleaved tau in neuropil threads, neuritic plaques, and neurofibrillary tangles of Alzheimer's disease.
    Guo H; Albrecht S; Bourdeau M; Petzke T; Bergeron C; LeBlanc AC
    Am J Pathol; 2004 Aug; 165(2):523-31. PubMed ID: 15277226
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Visual association pathology in preclinical Alzheimer disease.
    McKee AC; Au R; Cabral HJ; Kowall NW; Seshadri S; Kubilus CA; Drake J; Wolf PA
    J Neuropathol Exp Neurol; 2006 Jun; 65(6):621-30. PubMed ID: 16783172
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The value of cross sectional neuroanatomical studies as a conceptual framework for prospective clinicopathological studies.
    Dickson DW
    Neurobiol Aging; 1997; 18(4):382-6; discussion 389-92. PubMed ID: 9330967
    [No Abstract]   [Full Text] [Related]  

  • 20. Pathological substrates of cognitive decline in Alzheimer's disease.
    Giannakopoulos P; Gold G; von Gunten A; Hof PR; Bouras C
    Front Neurol Neurosci; 2009; 24():20-29. PubMed ID: 19182459
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.